Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
2.140
-0.120 (-5.31%)
Dec 5, 2025, 4:00 PM EST - Market closed
APUS Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 6.99 | 0 | 0.41 | 0.01 | 0.17 |
| Cash & Short-Term Investments | 6.99 | 0 | 0.41 | 0.01 | 0.17 |
| Cash Growth | 26194.14% | -99.16% | 6551.77% | -96.40% | - |
| Prepaid Expenses | 2.1 | 0.01 | 0.01 | - | 0 |
| Total Current Assets | 9.09 | 0.01 | 0.42 | 0.01 | 0.17 |
| Accounts Payable | 0 | - | - | - | 0.01 |
| Accrued Expenses | 0.23 | 0.7 | 0.12 | 0.04 | - |
| Short-Term Debt | 0.5 | 0.33 | - | 0.28 | - |
| Current Income Taxes Payable | - | - | - | 0 | - |
| Total Current Liabilities | 1.09 | 1.02 | 0.12 | 0.32 | 0.01 |
| Long-Term Debt | - | 0.35 | 0.27 | 0.4 | 0.4 |
| Common Stock | 0.13 | 0.08 | 0.08 | 0.1 | 0.1 |
| Additional Paid-In Capital | 17.27 | 2.95 | 2.95 | 1.41 | 1.22 |
| Retained Earnings | -9.24 | -4.39 | -3 | -2.22 | -1.56 |
| Total Liabilities & Equity | 9.25 | 0.01 | 0.42 | 0.01 | 0.17 |
| Total Debt | 0.5 | 0.67 | 0.27 | 0.68 | 0.4 |
| Net Cash (Debt) | 6.49 | -0.67 | 0.14 | -0.68 | -0.23 |
| Net Cash Per Share | 0.67 | -0.08 | 0.03 | -0.18 | -0.06 |
| Filing Date Shares Outstanding | 12.58 | 8.19 | 7.9 | 5.77 | 3.85 |
| Total Common Shares Outstanding | 12.58 | 7.9 | 7.9 | 5.77 | 3.85 |
| Working Capital | 8 | -1.01 | 0.3 | -0.31 | 0.16 |
| Book Value Per Share | 0.65 | -0.17 | 0.00 | -0.12 | -0.06 |
| Tangible Book Value | 8.16 | -1.36 | 0.03 | -0.71 | -0.24 |
| Tangible Book Value Per Share | 0.65 | -0.17 | 0.00 | -0.12 | -0.06 |
Source: S&P Capital IQ. Standard template.
Financial Sources.